Financhill
Back

Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
41

PSTV
Plus Therapeutics

Last Price:
1.15
Seasonality Move:
2.43%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.47
Seasonality Move:
27.93%
Sell
41
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy, Sell or Hold?

  • The current Plus Therapeutics [PSTV] share price is $1.17. The Score for PSTV is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.48. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSTV Stock Price Chart

What is Plus Therapeutics's stock price today?

  • The Plus Therapeutics share price today is $1.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

PSTV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 38.61 Sell
Chaikin Money Flow: -26085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.2 - 1.34) Sell
Bollinger Bands (100): (1.25 - 1.57) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.57 Sell
Relative Strength Index (14 RSI): 22.44 Sell
Chaikin Money Flow: -265638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 7.75) Sell
Bollinger Bands (100): (7.43 - 15.15) Sell

PSTV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.31 Sell
20-day SMA: 1.28 Sell
50-day SMA: 1.32 Sell
200-day SMA: 1.65 Sell
8-day EMA: 1.28 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.33 Sell
200-day EMA: 1.67 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.6 Sell
20-day SMA: 4.18 Sell
50-day SMA: 8.81 Sell
200-day SMA: 12.34 Sell
8-day EMA: 3.65 Sell
20-day EMA: 4.83 Sell
50-day EMA: 7.67 Sell
200-day EMA: 10.3 Sell

Plus Therapeutics Earnings Growth & PSTV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):